LncRNA Airn maintains LSEC differentiation to alleviate liver fibrosis via the KLF2-eNOS-sGC pathway.

MLA

Chen, Ting, et al. “LncRNA Airn Maintains LSEC Differentiation to Alleviate Liver Fibrosis via the KLF2-ENOS-SGC Pathway.” BMC Medicine, vol. 20, no. 1, Sept. 2022, pp. 1–19. EBSCOhost, https://doi.org/10.1186/s12916-022-02523-w.

APA

Chen, T., Shi, Z., Zhao, Y., Meng, X., Zhao, S., Zheng, L., Han, X., Hu, Z., Yao, Q., Lin, H., Du, X., Zhang, K., Han, T., & Hong, W. (2022). LncRNA Airn maintains LSEC differentiation to alleviate liver fibrosis via the KLF2-eNOS-sGC pathway. BMC Medicine, 20(1), 1–19. https://doi.org/10.1186/s12916-022-02523-w

Chicago

Chen, Ting, Zhemin Shi, Yanmian Zhao, Xiaoxiang Meng, Sicong Zhao, Lina Zheng, Xiaohui Han, et al. 2022. “LncRNA Airn Maintains LSEC Differentiation to Alleviate Liver Fibrosis via the KLF2-ENOS-SGC Pathway.” BMC Medicine 20 (1): 1–19. doi:10.1186/s12916-022-02523-w.